Accelerated development of a recombinant protein vaccine against COVID-19 by integrating the SARS-CoV-2 S-protein antigen with a new delivery system

The objective of this proposal is to develop a new candidate recombinant protein vaccine for the new coronavirus disease 2019 (COVID-19) based on a novel protein delivery and adjuvant technology, iPDT. If successful, this research will advance another COVID-19 vaccine candidate(s) to the pipeline toward clinical use. The causative agent of COVID-19 is SARS coronavirus […]

Read More
Genomics profiling of peritoneal mesothelioma and patient-derived xenograft models for in vivo biomarker validation

Peritoneal Mesothelioma (PM) is a rare type of cancer affecting the protective membrane surrounding the abdominal cavity and the second most common type of mesothelioma, consisting about 10-20% of the diagnosed cases. The underlying cellular and molecular mechanisms of peritoneal mesothelioma pathology are greatly understudied. In this proposal, we aim to enhance the current knowledge […]

Read More
In-vivo translation of neuronal cell regeneration/reprogramming protein in mouse with chronic spinal cord injury

Chronic spinal cord injury (SCI) is a debilitating disease with enormous economic and personal impact. To date there is no approved treatment that can repair the severed nerves found in SCI. The research project entails translational development of an early stage experimental protein drug candidate that has shown remarkable ability to trigger dormant human stem […]

Read More
In-silico identification of driver alterations and prediction of therapeutics targeting actionable drivers in prostate cancer

Cancer arises as a result of deleterious aberrations in the DNA, RNA and proteins of cells. The accumulation of genetic abnormalities, over lifetime, perturbs critical functions of cells, which may ultimately give rise to tumor. However, vast majority of these aberrations are not essential and only small fractions, known as “driver” genes, are critical for […]

Read More